Ariad shares up premarket after Iclusig trial results over the weekend

Shares of Ariad Pharmaceuticals were up this morning in premarket trading after results of two trials of its approved cancer drug, Iclusig, were announced over the weekend...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.